Regulation of inflammation by selenium and selenoproteins: Impact on eicosanoid biosynthesis

Journal of Nutritional Science

Volumn 2, Issue , 2013, Pages 1-13

  Mattmiller, S A ^a   Carlson, Bradley A ^b   Sordillo, Lorraine M ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Eicosanoid biosynthesis; Inflammation; Selenium; Selenoproteins

Indexed keywords

EID: 84920718085     PISSN: 20486790     EISSN: None     Source Type: Journal    
DOI: 10.1017/jns.2013.17     Document Type: Article

References (105)

1. Lloyd-Jones D, Adams R, Carnethon M, et al. (2009) Heart disease and stroke statistics - 2009 update. Circulation 119, e21-e181.
2. Boosalis MG (2008) The role of selenium in chronic disease. Nutr Clin Pract 23, 152-160.
3. Sordillo LM, Contreras GA & Aitken SL (2009) Metabolic factors affecting the inflammatory response of periparturient dairy cows. Anim Health Res Rev 10, 53-63.
4. Van der Linden MW, Van der Bij S, Welsing P, et al. (2009) The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal antiinflammatory drugs. Ann Rheum Dis 68, 668-673.
5. Banning A, Florian S, Deubel S, et al. (2008) GPx2 counteracts PGE2 production by dampening COX-2 and mPGES-1 expression in human colon cancer cells. Antioxid Redox Signal 10, 1491-1500.
6. Flores-Mateo G, Navas-Acien A, Pastor-Barriuso R, et al. (2006) Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr 84, 762-773.
7. Aitken SL, Karcher EL, Rezamand P, et al. (2009) Evaluation of antioxidant and proinflammatory gene expression in bovine mammary tissue during the periparturient period. J Dairy Sci 92, 589-598.
8. Cheng AWM, Stabler TV, Bolognesi M, et al. (2011) Selenomethionine inhibits IL-1β inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes. Osteoarthritis Cartilage 19, 118-125.
9. Moxon AL & Rhian M (1943) Selenium poisoning. Physiol Rev 23, 305-337.
10. Muth O, Oldfield J, Remmert L, et al. (1958) Effects of selenium and vitamin E on white muscle disease. Science 128, 1090-1091.
11. Chen X, Yang G, Chen J, et al. (1980) Studies on the relations of selenium and Keshan disease. Biol Trace Elem Res 2, 91-107.
12. Monsen ER (2000) Dietary reference intakes for the antioxidant nutrients: vitamin C, vitamin E, selenium, and carotenoids. J Am Diet Assoc 100, 637-640.
13. Abdo KM (1994) NTP Technical Report on Toxicity Studies of Sodium Selenate and Sodium Selenite (CAS Nos. 13410-01-0 and 10102-18-8) Administered in Drinking Water to F344/N Rats and B6C3F1 Mice. Research Triangle Park: NTP Central Data Management.
14. Huang T-S, Shyu Y-C, Chen H-Y, et al. (2013) Effect of parenteral selenium supplementation in critically ill patients: a systematic review and meta-analysis. PLOS ONE 8, e54431.
15. Ghaemi S, Forouhari S, Dabbaghmanesh M, et al. (2013) A prospective study of selenium concentration and risk of preeclampsia in pregnant Iranian women: a nested case-control study. Biol Trace Elem Res 152, 174-179.
16. Tirosh O, Levy E & Reifen R (2007) High selenium diet protects against TNBS-induced acute inflammation, mitochondrial dysfunction, and secondary necrosis in rat colon. Nutrition 23, 878-886.
17. Lippman SM, Klein EA, Goodman PJ, et al. (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers:the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301, 39-51.
18. Hamilton JW & Tappel AL (1963) Lipid antioxidant activity in tissues and proteins of selenium-fed animals. J Nutr 79, 493-502.
19. Sordillo LM & Aitken SL (2009) Impact of oxidative stress on the health and immune function of dairy cattle. Vet Immunol Immunopathol 128, 104-109.
20. Sies H (1986) Biochemistry of oxidative stress. Angew Chemie Int Edit 25, 1058-1071.
21. Kernstock RM & Girotti AW (2008) New strategies for the isolation and activity determination of naturally occurring type-4 glutathione peroxidase. Protein Express Purif 62, 216-222.
22. Thomas JP, Maiorino M, Ursini F, et al. (1990) Protective action of phospholipid hydroperoxide glutathione peroxidase against membrane-damaging lipid peroxidation. In situ reduction of phospholipid and cholesterol hydroperoxides. J Biol Chem 265, 454-461.
23. Pushpa-Rekha TR, Burdsall AL, Oleksa LM, et al. (1995) Rat phospholipid-hydroperoxide glutathione peroxidase: cDNA cloning and identification of multiple transcription and translation start sites. J Biol Chem 270, 26993-26999.
24. Liang H, Remmen HV, Frohlich V, et al. (2007) Gpx4 protects mitochondrial ATP generation against oxidative damage. Biochem Biophys Res Commun 356, 893-898.
25. Fairweather-Tait SJ, Bao Y, Broadley MR, et al. (2011) Selenium in human health and disease. Antioxid Redox Signal 14, 1337-1383.
26. Jeong D-W, Kim TS, Chung YW, et al. (2002) Selenoprotein W is a glutathione-dependent antioxidant in vivo. FEBS Lett 517, 225-228.
27. Praticò D, Tangirala RK, Rader DJ, et al. (1998) Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE-deficient mice. Nat Med 4, 1189-1192.
28. Monnier L, Mas E, Ginet C, et al. (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295, 1681-1687.
29. Ranjan R, Swarup D, Naresh R, et al. (2005) Enhanced erythrocytic lipid peroxides and reduced plasma ascorbic acid, and alteration in blood trace elements level in dairy cows with mastitis. Vet Res Comm 29, 27-34.
30. Bellinger FP, Raman AV, Reeves MA, et al. (2009) Regulation and function of selenoproteins in human disease. Biochem J 422, 11-22.
31. Lu J & Holmgren A (2009) Selenoproteins. J BiolChem284, 723-727.
32. Sordillo LM (2013) Selenium-dependent regulation of oxidative stress and immunity in periparturient dairy cattle. Vet Med Int2013, 154045.
33. Guo Z, Ran Q, Roberts LJ II, et al. (2008) Suppression of atherogenesis by overexpression of glutathione peroxidase-4 in apolipoprotein E-deficient mice. Free Radic Biol Med 44, 343-352.
34. Dabkowski ER, Williamson CL & Hollander JM (2008) Mitochondria-specific transgenic overexpression of phospholipid hydroperoxide glutathione peroxidase (GPx4) attenuates ischemia/reperfusion-associated cardiac dysfunction. Free Radic Biol Med 45, 855-865.
35. Björnstedt M, Hamberg M, Kumar S, et al. (1995) Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols. J Biol Chem 270, 11761-11764.
36. Trigona WL, Mullarky IK, Cao Y, et al. (2006) Thioredoxin reductase regulates the induction of haem oxygenase-1 expression in aortic endothelial cells. Biochem J 394, 207-216.
37. Rock C & Moos PJ (2010) Selenoprotein P protects cells from lipid hydroperoxides generated by 15-LOX-1. Prostaglandins Leukot Essent Fatty Acids 83, 203-210.
38. George J, Afek A, Shaish A, et al. (2001) 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation 104, 1646-1650.
39. Schafer FQ & Buettner GR (2001) Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30, 1191-1212.
40. Into T, Inomata M, Nakashima M, et al. (2008) Regulation of MyD88-dependent signaling events by S nitrosylation retards tolllike receptor signal transduction and initiation of acute-phase immune responses. Mol Cell Biol 28, 1338-1347.
41. Al-Gayyar MM, Abdelsaid MA, Matragoon S, et al. (2011) Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity. Br J Pharmacol 164, 170-180.
42. Kataoka K, Tokutomi Y, Yamamoto E, et al. (2011) Apoptosis signal-regulating kinase 1 deficiency eliminates cardiovascular injuries induced by high-salt diet. J Hypertens 29, 76-84.
43. Saitoh M, Nishitoh H, Fujii M, et al. (1998) Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17, 2596-2606.
44. Vunta H, Davis F, Palempalli UD, et al. (2007) The antiinflammatory effects of selenium are mediated through 15-deoxy-12,14-prostaglandin J2 in macrophages. J Biol Chem 282, 17964-17973.
45. Vunta H, Belda BJ, Arner RJ, et al. (2008) Selenium attenuates pro-inflammatory gene expression in macrophages. Mol Nutr Food Res 52, 1316-1323.
46. Allard JP, Aghdassi E, Chau J, et al. (1998) Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection. Am J Clin Nutr 67, 143-147.
47. Gladyshev VN, Stadtman TC, Hatfield DL, et al. (1999) Levels of major selenoproteins in T cells decrease during HIV infection and low molecular mass selenium compounds increase. Proc Natl Acad Sci U S A 96, 835-839.
48. Jamaluddin M, Wang S, Boldogh I, et al. (2007) TNF-α-induced NF-κB/RelA Ser276 phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway. Cell Signal 19, 1419-1433.
49. Meyer M, Schreck R & Baeuerle PA (1993) H2O2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12, 2005-2015.
50. Matthews JR, Wakasugi N, Virelizier JL, et al. (1992) Thioredoxin regulates the DNA binding activity of NF-κB by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res 20, 3821-3830.
51. Hirota K, Murata M, Sachi Y, et al. (1999) Distinct roles of thioredoxin in the cytoplasm and in the nucleus: a two-step mechanism of redox regulation of transcription factor NF-κB. J Biol Chem 274, 27891-27897.
52. Schmitz G & Ecker J (2008) The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 47, 147-155.
53. Roberts LJ II & Morrow JD (2000) Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28, 505-513.
54. Lakshmi S, Padmaja G, Kuppusamy P, et al. (2009) Oxidative stress in cardiovascular disease. Indian J Biochem Biophys 46, 421-440.
55. Spiteller P & Spiteller G (1997) 9-Hydroxy-10,12-octadecadienoic acid (9-HODE) and 13-hydroxy-9,11-octadecadienoic acid (13-HODE): excellent markers for lipid peroxidation. Chem Phys Lipids 89, 131-139.
56. Xie WL, Chipman JG, Robertson DL, et al. (1991) Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A 88, 2692-2696.
57. Kurumbail RG, Kiefer JR & Marnett LJ (2001) Cyclooxygenase enzymes: catalysis and inhibition. Curr Opin Struct Biol 11, 752-760.
58. Dubois RN, Abramson SB, Crofford L, et al. (1998) Cyclooxygenase in biology and disease. FASEB J 12, 1063-1073.
59. Kuhn H & Thiele BJ (1999) The diversity of the lipoxygenase family: many sequence data but little information on biological significance. FEBS Lett 449, 7-11.
60. Chiang N, Arita M & Serhan CN (2005) Anti-inflammatory circuitry:lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot Essent Fatty Acids 73, 163-177.
61. Kuhn H & O’Donnell VB (2006) Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res 45, 334-356.
62. Yuan ZX, Rapoport SI, Soldin SJ, et al. (2013) Identification and profiling of targeted oxidized linoleic acid metabolites in rat plasma by quadrupole time-of-flight mass spectrometry. Biomed Chromatogr 27, 422-432.
63. Oh SF, Dona M, Fredman G, et al. (2012) Resolvin E2 formation and impact in inflammation resolution. J Immunol 188, 4527-4534.
64. Merched AJ, Ko K, Gotlinger KH, et al. (2008) Atherosclerosis:evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J 22, 3595-3606.
65. Serhan CN & Savill J (2005) Resolution of inflammation: the beginning programs the end. Nat Immunol 6, 1191-1197.
66. Arnaud J, Bost M, Vitoux D, et al. (2007) Effect of low dose antioxidant vitamin and trace element supplementation on the urinary concentrations of thromboxane and prostacyclin metabolites. J Am Coll Nutr 26, 405-411.
67. Meydani M (1992) Modulation of the platelet thromboxane A2 and aortic prostacyclin synthesis by dietary selenium and vitamin E. Biol Trace Elem Res 33, 79-86.
68. Haberland A, Neubert K, Kruse I, et al. (2001) Consequences of long-term selenium-deficient diet on the prostacyclin and thromboxane release from rat aorta. Biol Trace Elem Res 81, 71-78.
69. Maddox JF, Reddy CC, Eberhart RJ, et al. (1991) Dietary selenium effects on milk eicosanoid concentration in dairy cows during coliform mastitis. Prostaglandins 42, 369-378.
70. Gandhi UH, Kaushal N, Ravindra KC, et al. (2011) Selenoprotein-dependent upregulation of hematopoietic prostaglandin D2 synthase in macrophages is mediated through the activation of peroxisome proliferator-activated receptor (PPAR)γ. J Biol Chem 286, 27471-27482.
71. Imai H, Narashima K, Arai M, et al. (1998) Suppression of leukotriene formation in RBL-2H3 cells that overexpressed phospholipid hydroperoxide glutathione peroxidase. J Biol Chem 273, 1990-1997.
72. Schnurr K, Belkner J, Ursini F, et al. (1996) The selenoenzyme phospholipid hydroperoxide glutathione peroxidase controls the activity of the 15-lipoxygenase with complex substrates and preserves the specificity of the oxygenation products. J Biol Chem 271, 4653-4658.
73. Walther M, Holzhutter H-G, Kuban RJ, et al. (1999) The inhibition of mammalian 15-lipoxygenases by the anti-inflammatory drug ebselen: dual-type mechanism involving covalent linkage and alteration of the iron ligand sphere. Mol Pharmacol 56, 196-203.
74. Marnett LJ, Rowlinson SW, Goodwin DC, et al. (1999) Arachidonic acid oxygenation by COX-1 and COX-2. J Biol Chem 274, 22903-22906.
75. Cook H & Lands WEM (1976) Mechanism for suppression of cellular biosynthesis of prostaglandins. Nature 260, 630-632.
76. Smith WL & Lands WEM (1972) Oxygenation of polyunsaturated fatty acids during prostaglandin biosynthesis by sheep vesicular glands. Biochemistry 11, 3276-3285.
77. Wade ML, Voelkel NF & Fitzpatrick FA (1995) “Suicide” inactivation of prostaglandin I2 synthase: characterization of mechanism-based inactivation with isolated enzyme and endothelial cells. Arch Biochem Biophys 321, 453-458.
78. Jones DA & Fitzpatrick FA (1990) “Suicide” inactivation of thromboxane A2 synthase. Characteristics of mechanism-based inactivation with isolated enzyme and intact platelets. J Biol Chem 265, 20166-20171.
79. Hampel G, Watanabe K, Weksler BB, et al. (1989) Selenium deficiency inhibits prostacyclin release and enhances production of platelet activating factor by human endothelial cells. Biochim Biophys Acta 1006, 151-158.
80. Hwang J-T, Kim YM, Surh Y-J, et al. (2006) Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMP-activated protein kinase in colon cancer cells. Cancer Res 66, 10057-10063.
81. Pei Z, Li H, Guo Y, et al. (2010) Sodium selenite inhibits the expression of VEGF, TGFβ1 and IL-6 induced by LPS in human PC3 cells via TLR4-NF-KB signaling blockage. Int Immunopharmacol 10, 50-56.
82. Coussens LM, Zitvogel L & Palucka AK (2013) Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 339, 286-291.
83. Sheng H, Shao J, Morrow JD, et al. (1998) Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58, 362-366.
84. Avis I, Hong SH, Martínez A, et al. (2001) Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J 15, 2007-2009.
85. Ghosh J (2004) Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenase. Biochem Biophys Res Commun 315, 624-635.
86. Heirman I, Ginneberge D, Brigelius-Flohé R, et al. (2006) Blocking tumor cell eicosanoid synthesis by GPx4 impedes tumor growth and malignancy. Free Radic Biol Med 40, 285-294.
87. Quinn MT, Parthasarathy S, Fong LG, et al. (1987) Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci U S A 84, 2995-2998.
88. Lewis P, Stefanovic N, Pete J, et al. (2007) Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice. Circulation 115, 2178-2187.
89. Panicker S, Swathy S & John F (2012) Impact of selenium on the leukotriene B4 synthesis pathway during isoproterenolinduced myocardial infarction in experimental rats. Inflammation 35, 74-80.
90. Shrimali RK, Weaver JA, Miller GF, et al. (2007) Selenoprotein expression is essential in endothelial cell development and cardiac muscle function. Neuromuscul Disord 17, 135-142.
91. Cao Y-Z, Reddy CC & Sordillo LM (2000) Altered eicosanoid biosynthesis in selenium-deficient endothelial cells. Free Radic Biol Med 28, 381-389.
92. Sordillo LM, Streicher KL, Mullarky IK, et al. (2008) Selenium inhibits 15-hydroperoxyoctadecadienoic acid-induced intracellular adhesion molecule expression in aortic endothelial cells. Free Radic Biol Med 44, 34-43.
93. Sordillo LM, Weaver JA, Cao Y-Z, et al. (2005) Enhanced 15-HPETE production during oxidant stress induces apoptosis of endothelial cells. Prostaglandins Other Lipid Mediat 76, 19-34.
94. Weaver JA, Maddox JF, Cao YZ, et al. (2001) Increased 15-HPETE production decreases prostacyclin synthase activity during oxidant stress in aortic endothelial cells. Free Radic Biol Med 30, 299-308.
95. Rydberg EK, Krettek A, Ullström C, et al. (2004) Hypoxia increases LDL oxidation and expression of 15-lipoxygenase-2 in human macrophages. Arterioscler Thromb Vasc Biol 24, 2040-2045.
96. Takahashi K, Takeya M & Sakashita N (2002) Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals. Med Electron Microsc 35, 179-203.
97. Cao Y-Z, Weaver JA, Chana Reddy C, et al. (2002) Selenium deficiency alters the formation of eicosanoids and signal transduction in rat lymphocytes. Prostaglandins Other Lipid Mediat 70, 131-143.
98. Carlson B, Yoo M-H, Sano Y, et al. (2009) Selenoproteins regulate macrophage invasiveness and extracellular matrix-related gene expression. BMC Immunol 10, 57.
99. Prabhu KS, Zamamiri-Davis F, Stewart JB, et al. (2002) Selenium deficiency increases the expression of inducible nitric oxide synthase in RAW 264.7 macrophages: role of nuclear factor-κB in up-regulation. Biochem J 366, 203-209.
100. Zamamiri-Davis F, Lu Y, Thompson JT, et al. (2002) Nuclear factor-κB mediates over-expression of cyclooxygenase-2 during activation of RAW 264.7 macrophages in selenium deficiency. Free Radic Biol Med 32, 890-897.
101. Youn H-S, Lim HJ, Choi YJ, et al. (2008) Selenium suppresses the activation of transcription factor NF-κB and IRF3 induced by TLR3 or TLR4 agonists. Int Immunopharmacol 8, 495-501.
102. Nam KN, Koketsu M & Lee EH (2008) 5-Chloroacetyl-2-amino-1,3-selenazoles attenuate microglial inflammatory responses through NF-κB inhibition. Eur J Pharmacol 589, 53-57.
103. Serhan CN & Chiang N (2008) Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol 153, Suppl. 1, S200-S215.
104. Heras IL, Palomo M & Madrid Y (2011) Selenoproteins: the key factor in selenium essentiality. State of the art analytical techniques for selenoprotein studies. Anal Bioanal Chem 400, 1717-1727.
105. Kryukov GV, Castellano S, Novoselov SV, et al. (2003) Characterization of mammalian selenoproteomes. Science 300, 1439-1443.